SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-019612
Filing Date
2024-03-04
Accepted
2024-03-04 17:24:56
Documents
15
Period of Report
2024-02-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea0201156-8k425_aditxt.htm   iXBRL 8-K 39378
2 THIRD AMENDMENT TO AGREEMENT AND PLAN OF MERGER DATED AS OF FEBRUARY 29, 2024, B ea0201156ex10-1_aditxt.htm EX-10.1 16666
  Complete submission text file 0001213900-24-019612.txt   239775

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE adtx-20240229.xsd EX-101.SCH 3009
4 XBRL LABEL FILE adtx-20240229_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE adtx-20240229_pre.xml EX-101.PRE 22355
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0201156-8k425_aditxt_htm.xml XML 3706
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 24716052
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)